ELI LILLY (LLY)
Sector: Health Care
Named Executive Officers
Compensation data for top executives (showing up to 3 years of data)
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| David A. Ricks Chair, President, and Chief Executive Officer | 2025 | $1,700,000 | $0 | $23,325,000 | $0 | $6,485,500 | $736,201 | $36,698,337 |
| 2024 | $1,690,385 | $0 | $19,749,324 | $0 | $5,705,049 | $351,685 | $29,242,926 | |
| 2023 | $1,621,154 | $0 | $18,840,250 | $0 | $4,401,433 | $263,073 | $26,565,732 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Daniel M. Skovronsky, M.D., Ph.D. Executive Vice President, Chief Scientific and Product Officer and President, Lilly Research Labs | 2025 | $1,490,385 | $0 | $12,000,000 | $0 | $3,249,039 | $159,307 | $17,786,576 |
| 2024 | $1,430,769 | $0 | $7,499,895 | $0 | $3,219,230 | $206,980 | $12,638,744 | |
| 2023 | $1,330,769 | $0 | $7,483,400 | $0 | $2,408,692 | $79,846 | $11,853,929 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Anat Hakim Executive Vice President, General Counsel and Secretary | 2025 | $1,000,000 | $0 | $6,000,000 | $0 | $2,180,000 | $162,570 | $9,845,518 |
| 2024 | $1,000,000 | $0 | $3,950,071 | $0 | $2,250,000 | $66,834 | $7,478,426 | |
| 2023 | $980,769 | $0 | $3,952,500 | $0 | $1,775,192 | $58,846 | $7,006,737 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Lucas Montarce Executive Vice President and Chief Financial Officer | 2025 | $1,000,000 | $0 | $5,000,000 | $0 | $2,180,000 | $60,000 | $8,483,315 |
| 2024 | $664,639 | $0 | $1,067,135 | $0 | $1,114,558 | $39,878 | $2,948,519 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Jake Van Naarden Executive Vice President and President, Lilly Oncology and Head of Corporate Business Development | 2025 | $920,192 | $0 | $4,500,000 | $0 | $2,006,019 | $72,519 | $7,586,097 |
| 2024 | $890,385 | $0 | $2,700,248 | $0 | $2,003,366 | $113,062 | $5,773,948 | |
| 2023 | $830,769 | $0 | $2,424,200 | $0 | $1,503,692 | $49,846 | $4,886,520 |